$AIM This is long, but here is some linkage I've found that has boosted my confidence in Ampligen. We know about the ties to Japan and now the clinical trial here in the US, but here are a few other things that can help us connect the dots. Goethe University in Frankfurt Germany conducted a lab study on therapeutics recently. We know that Rintatolimod (Ampligen) was in it and they released an article the same day the clinical trial was posted. They did not name Ampligen in it, however they talked about several therapeutics showing promise and that clinical trials in the US would be starting. They did discuss a few things that I think show promise here. Their study used Colon cells, guess what Ampligen has a clinical study on right now? You guessed it, colorectal cancer (bowel, colon & rectal cancer). Next thing is that they talk about translation inhibition, which is exactly what Ampligen does as a RNA translation ihibitor. Continued...
  • 13
13 Likes